TrialCancer science2017

Efficacy and safety of nivolumab in Japanese patients with advanced or recurrent squamous non-small cell lung cancer.

Toyoaki Hida et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.